Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 5386-5389

  Seibert, Christopher W ^a   Rahmat, Saad ^a   Krammer, Florian ^a   Palese, Peter ^a   Bouvier, Nicole M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; SIALIDASE;

ARTICLE; AUSTRALIA; DISEASE TRANSMISSION; DRUG MECHANISM; DRUG SENSITIVITY; GUINEA PIG; IC 50; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SINGAPORE; VIRUS MUTATION; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; DRUG RESISTANCE, VIRAL; GUINEA PIGS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MUTATION; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR;

CAVIA; ORTHOMYXOVIRIDAE;

EID: 84861316119     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00151-12     Document Type: Article

References (32)

1. Baz M, Abed Y, Simon P, Hamelin ME, Boivin G. 2010. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J. Infect. Dis. 201:740-745.
2. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272-1275.
3. Bloom JD, Nayak JS, Baltimore D. 2011. A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS One 6:e22201.
4. Bouvier NM, Lowen AC, Palese P. 2008. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J. Virol. 82:10052-10058.
5. Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM, Jr. 2012. The global spread of drug-resistant influenza. J. R. Soc. Interface 9:648-656.
6. Chen LF, et al. 2011. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients-North Carolina, 2009. J. Infect. Dis. 203:838-846.
7. Duan S, et al. 2010. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog. 6:e1001022.
8. Fodor E, et al. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
9. Ginting TE, et al. 2012. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J. Virol. 86:121-127.
10. Hai R, et al. 2010. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J. Virol. 84:4442-4450.
11. Hamelin MA, et al. 2010. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog. 6:e1001015.
12. Harvala H, et al. 2010. The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalized immunocompromised patients in Scotland, November-December, 2009. Euro Surveill. 15:pii:19536.
13. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. 2009. Oseltamivir-resistant influenza viruses A(H1N1), Norway, 2007-08. Emerg. Infect. Dis. 15:155-162.
14. Hurt AC, et al. 2011. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N. Engl. J. Med. 365:2541-2542.
15. Hurt AC, et al. 2011. Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill. 16:pii:19884.
16. Ives JAL, et al. 2002. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 55:307-317.
17. Kiso M, et al. 2010. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog. 6:e1001079.
18. Kramarz P, Monnet D, Nicoli A, Yilmaz C, Ciancio B. 2009. Use of oseltamivir in 12 European countries between 2002 and 2007-lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. Euro Surveill. 14:pii:19112.
19. Lowen AC, Mubareka S, Steel J, Palese P. 2007. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 3:e151.
20. Lowen AC, Mubareka S, Tumpey TM, García-Sastre A, Palese P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 103:9988-9992.
21. Mai LQ, et al. 2010. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N. Engl. J. Med. 362:86-87.
22. Mandelboim M, Hindiyeh M, Meningher T, Mendelson E. 2010. Possible transmission of pandemic (H1N1) 2009 virus with oseltamivir resistance. Emerg. Infect. Dis. 16:873-874. (Letter.)
23. Meijer A, et al. 2009. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect. Dis. 15:552-560.
24. Memoli MJ, et al. 2011. Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J. Infect. Dis. 203:348-357.
25. Moore C, et al. 2011. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J. Infect. Dis. 203:18-24.
26. Potier M, Mameli L, Belisle M, Dallaire L, Meclancon SB. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
27. Rameix-Welti M-A, Enouf V, Cuvelier F, Jeannin P, van der Werf S. 2008. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog. 4:e1000103.
28. Seibert CW, et al. 2010. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J. Virol. 84:11219-11226.
29. Steel J, Palese P, Lowen AC. 2011. Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J. Virol. 85:1400-1402.
30. Steel J, et al. 2010. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J. Virol. 84:21-26.
31. Tramontana AR, et al. 2010. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg. Infect. Dis. 16:1068-1075.
32. van der Vries E, et al. 2011. Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets. PLoS Pathog. 7:e1002276.